Teleflex Incorporated (NYSE:TFX) Shares Sold by Davis R M Inc.

Davis R M Inc. cut its position in Teleflex Incorporated (NYSE:TFX) by 44.4% in the fourth quarter, Holdings Channel reports. The firm owned 1,263 shares of the medical technology company’s stock after selling 1,008 shares during the period. Davis R M Inc.’s holdings in Teleflex were worth $225,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the company. Apollon Wealth Management LLC boosted its position in shares of Teleflex by 3.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after purchasing an additional 55 shares during the period. SRS Capital Advisors Inc. boosted its position in shares of Teleflex by 0.3% in the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after purchasing an additional 60 shares during the period. Tokio Marine Asset Management Co. Ltd. boosted its position in shares of Teleflex by 4.5% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after purchasing an additional 66 shares during the period. HighTower Advisors LLC boosted its position in shares of Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after purchasing an additional 66 shares during the period. Finally, Huntington National Bank boosted its position in shares of Teleflex by 32.5% in the 3rd quarter. Huntington National Bank now owns 310 shares of the medical technology company’s stock valued at $77,000 after purchasing an additional 76 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently issued reports on TFX. Raymond James cut Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Wednesday. Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price objective (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Finally, Wells Fargo & Company reduced their price objective on Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $182.63.

Teleflex Stock Performance

Shares of TFX stock opened at $135.46 on Thursday. The company has a market cap of $6.28 billion, a price-to-earnings ratio of 26.93, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The stock has a 50 day simple moving average of $168.73 and a 200-day simple moving average of $199.15. Teleflex Incorporated has a 12-month low of $128.55 and a 12-month high of $249.90. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. On average, equities analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.00%. The ex-dividend date is Friday, March 7th. Teleflex’s payout ratio is currently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.